Statins have recently been acknowledged for their proapoptotic and anticancerous effects on prostate cancer cells; for example, molecularly, simvastatin was reported to upregulate the expression of Annexin A10 protein but downregulate S100A4 expression, leading to the prevention and treatment activities in prostate cancer patients [128]. Here, ANXA10 is linked to prostate cancer.